Paul R. Crocker
Dow Street
Dundee, SCT, United Kingdom
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Sialoadhesin (CD169/Siglec-1) is an extended molecule that escapes inhibitory cis-interactions and synergizes with other macrophage receptors to promote phagocytosis.
Journal: Glycoconjugate journal
Published: December 12, 2022
Quantitative Proteomics of Polarised Macrophages Derived from Induced Pluripotent Stem Cells.
Journal: Biomedicines
Published: November 29, 2021
Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis.
Journal: Frontiers in immunology
Published: July 19, 2021
Activation of regulatory T cells triggers specific changes in glycosylation associated with Siglec-1-dependent inflammatory responses.
Journal: Wellcome open research
Published: May 12, 2021
Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 23, 2020
Siglec and anti-Siglec therapies.
Journal: Current opinion in chemical biology
Published: November 05, 2020
Behavior of glycolylated sialoglycans in the binding pockets of murine and human CD22.
Journal: iScience
Published: October 05, 2020
Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation.
Journal: Journal of biomedical science
Published: August 12, 2020
Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10.
Journal: iScience
Published: August 04, 2020
Unravelling the health status of brachycephalic dogs in the UK using multivariable analysis.
Journal: Scientific reports
Published: June 09, 2020
Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10.
Journal: iScience
Published: April 17, 2020
Last Updated: 09/26/2026